Newsletter Sign Up

Response to Health Canada on the National Strategy for High-Cost Drugs for Rare Diseases

BioAlberta Submission re National Rare Disease Strategy 2021.03.26Download

Sign up for our newsletter

This field is for validation purposes and should be left unchanged.

Thank you to

Our Corporate Members

platinum

Novartis
Deloitte

Gold

University of Alberta logo
novo nordisk logo
boehringer ingelheim logo
Roche logo
innovate calgary logo
innovative-medicines-canada
biotalent-logo
abbvie-logo

Silver

Sanofi Logo
Biogen-Logo
takeda-logo
Bausch_Health logo
Become a Member

780.425.3804

admin@bioalberta.ca

Suite 202
10055 – 106 Street NW
Edmonton, AB, T5J 2Y2
Canada

Linkedin
© BioAlberta, 2024 | Site by Habit

Your search begins here.

Sign up for our newsletter

This field is for validation purposes and should be left unchanged.